After careful consideration, Dolomite Bio have decided to discontinue the manufacture and sales of the scRNA-Seq modular system. Dolomite Bio will be accepting orders of the scRNA-Seq modular system up until 30th June 2019 and will supply parts to current users until 30th June 2024. The discontinuation of the modular scRNA-Seq system is in keeping with Dolomite Bio’s practice of developing new and improved products with enhanced design and functionality. Customers are now able to purchase Dolomite Bio’s newest and most advanced single cell instrument, the Nadia instrument, which takes scRNA-Seq to the next level and provides additional capabilities and features. The Nadia Instrument combines automation and flexibility to generate high quality reproducible single cell data. This user-friendly platform offers a number of advantages, including high gene capture rates and a low cost per run and cell. It provides a fully automated, easy-to-use, high throughput solution for cost-effective single cell research, and is complemented by the Nadia Innovate, an open configurable development system that enables rapid protocol development and optimization. Dolomite Bio regrets any inconvenience this may have caused but is pleased to offer customers the Nadia, which provides better performance and capabilities.